Status:

NOT_YET_RECRUITING

Voll Degradable Shoulder Spacer FIH Study

Lead Sponsor:

Voll Medical Technologies Ltd.

Conditions:

Massive Rotator Cuff Tear

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with sy...

Eligibility Criteria

Inclusion

  • Main
  • Full thickness MRCT.
  • Male or female patients ≥ fifty (50) years of age, in general good health, independent, and can comply with all post-operative evaluations and visits.
  • Main

Exclusion

  • Documented evidence of a history of drug/alcohol abuse within 1 year of enrollment.
  • Concurrent participation in any other investigational clinical study.

Key Trial Info

Start Date :

October 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2027

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT07208448

Start Date

October 15 2025

End Date

December 31 2027

Last Update

October 6 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Voll Degradable Shoulder Spacer FIH Study | DecenTrialz